E-EDV-D682 | m-entrepreneurship.com

Product Name :
E-EDV-D682

Search keywords :
PNU-159682

drugId :
null

Target Vo:
Topoisomerase II

Target Vo Short Name :
TOP2

Moa_Name:
Epidermal growth factor receptor erbB1 modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Engeneic Ltd

Active Company_Name :
Engeneic Ltd

Active Indication_Name:
Pancreatic Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
TrkA Antibody
Acetyl CoA synthetaseAntibody
DLAT Antibody (YA912): DLAT Antibody (YA912) is an unconjugated, approximately 69 kDa, mouse-derived, anti-DLAT (YA912) monoclonal antibody. DLAT Antibody (YA912) can be used for: WB, ICC/IF, IP expriments in human, mouse background without labeling.

Author: Betaine hydrochloride

Related Posts